Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Cm082
2. N-((3s)-1-(dimethylcarbamoyl)pyrrolidin-3-yl)-5-((z)-(5-fluoro-2-oxo-1h-indol-3-ylidene)methyl)-2,4-dimethyl-1h-pyrrole-3-carboxamide
1. 1013920-15-4
2. Vorolanib [inn]
3. Yp8g3i74el
4. Cm082
5. N-[(3s)-1-(dimethylcarbamoyl)pyrrolidin-3-yl]-5-[(z)-(5-fluoro-2-oxo-1h-indol-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide
6. X-82
7. (s,z)-n-(1-(dimethylcarbamoyl)pyrrolidin-3-yl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1h-pyrrole-3-carboxamide
8. 1h-pyrrole-3-carboxamide, N-((3s)-1-((dimethylamino)carbonyl)-3-pyrrolidinyl)-5-((z)-(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl)-2,4-dimethyl-
9. N-((3s)-1-(dimethylcarbamoyl)pyrrolidin-3-yl)-5-((z)-(5-fluoro-2-oxo-1h-indol-3-ylidene)methyl)-2,4-dimethyl-1h-pyrrole-3-carboxamide
10. Unii-yp8g3i74el
11. Vorolanib [who-dd]
12. Schembl2439528
13. Chembl4297587
14. Gtpl11618
15. Eyp-1901
16. Cm-082
17. S6843
18. Db15247
19. Example 8 [wo2008033562a2]
20. Ac-35712
21. Hy-109019
22. Cs-0030517
23. X-082
24. Q27294638
Molecular Weight | 439.5 g/mol |
---|---|
Molecular Formula | C23H26FN5O3 |
XLogP3 | 1.6 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 3 |
Exact Mass | 439.20196787 g/mol |
Monoisotopic Mass | 439.20196787 g/mol |
Topological Polar Surface Area | 97.5 Ų |
Heavy Atom Count | 32 |
Formal Charge | 0 |
Complexity | 803 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Protein Kinase Inhibitors
Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)
ABOUT THIS PAGE
31
PharmaCompass offers a list of Vorolanib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Vorolanib manufacturer or Vorolanib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Vorolanib manufacturer or Vorolanib supplier.
PharmaCompass also assists you with knowing the Vorolanib API Price utilized in the formulation of products. Vorolanib API Price is not always fixed or binding as the Vorolanib Price is obtained through a variety of data sources. The Vorolanib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Vorolanib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vorolanib, including repackagers and relabelers. The FDA regulates Vorolanib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vorolanib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Vorolanib supplier is an individual or a company that provides Vorolanib active pharmaceutical ingredient (API) or Vorolanib finished formulations upon request. The Vorolanib suppliers may include Vorolanib API manufacturers, exporters, distributors and traders.
Vorolanib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Vorolanib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Vorolanib GMP manufacturer or Vorolanib GMP API supplier for your needs.
A Vorolanib CoA (Certificate of Analysis) is a formal document that attests to Vorolanib's compliance with Vorolanib specifications and serves as a tool for batch-level quality control.
Vorolanib CoA mostly includes findings from lab analyses of a specific batch. For each Vorolanib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Vorolanib may be tested according to a variety of international standards, such as European Pharmacopoeia (Vorolanib EP), Vorolanib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Vorolanib USP).